Related Experiment Video
Updated: Mar 26, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Necroptosis and Inflammation
1Physiological Chemistry Department, Genentech, Inc., South San Francisco, California 94080;
Abstract:
Necroptosis is a regulated form of necrosis, with the dying cell rupturing and releasing intracellular components that can trigger an innate immune response. Toll-like receptor 3 and 4 agonists, tumor necrosis factor, certain viral infections, or the T cell receptor can trigger necroptosis if the activity of the protease caspase-8 is compromised. Necroptosis signaling is modulated by the kinase RIPK1 and requires the kinase RIPK3 and the pseudokinase MLKL. Either RIPK3 deficiency or RIPK1 inhibition confers resistance in various animal disease models, suggesting that inflammation caused by necroptosis contributes to tissue damage and that inhibitors of these kinases could have therapeutic potential. Recent studies have revealed unexpected complexity in the regulation of cell death programs by RIPK1 and RIPK3 with the possibility that necroptosis is but one mechanism by which these kinases promote inflammation.
Insights
Necroptosis, a regulated cell death, triggers immune responses when caspase-8 is inhibited. Targeting RIPK1 or RIPK3 kinases may offer therapeutic benefits for inflammatory diseases.
Area of Science:
- Cellular Biology
- Immunology
- Molecular Medicine
Background:
- Necroptosis is a regulated form of necrosis.
- It involves cell rupture and release of intracellular components, initiating innate immune responses.
- Triggers include TLR agonists, TNF, viral infections, or TCR activation when caspase-8 is inhibited.
Purpose of the Study:
- To explore the role of RIPK1 and RIPK3 kinases in necroptosis.
- To investigate the therapeutic potential of inhibiting these kinases.
Main Methods:
- Analysis of necroptosis signaling pathways.
- Evaluation of RIPK3 deficiency and RIPK1 inhibition in disease models.
Main Results:
- Necroptosis signaling requires RIPK3 and MLKL, modulated by RIPK1.
- RIPK3 deficiency or RIPK1 inhibition confers resistance in animal models.
- Inflammation from necroptosis contributes to tissue damage.
Conclusions:
- RIPK1 and RIPK3 are key regulators of necroptosis and inflammation.
- Inhibitors of RIPK1 or RIPK3 show therapeutic potential for inflammatory conditions.
- These kinases may regulate cell death programs beyond necroptosis.
More Related Videos
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Inflammation
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Apoptosis

